P&K Skin Research Center Co. Ltd (347740) - Total Liabilities
Based on the latest financial reports, P&K Skin Research Center Co. Ltd (347740) has total liabilities worth ₩4.49 Billion KRW (≈ $3.04 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
P&K Skin Research Center Co. Ltd - Total Liabilities Trend (2018–2024)
This chart illustrates how P&K Skin Research Center Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 347740 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
P&K Skin Research Center Co. Ltd Competitors by Total Liabilities
The table below lists competitors of P&K Skin Research Center Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Koss Corporation
NASDAQ:KOSS
|
USA | $6.33 Million |
|
A-Tech Solution Co. Ltd
KQ:071670
|
Korea | ₩221.67 Billion |
|
RATH Aktiengesellschaft
VI:RAT
|
Austria | €72.27 Million |
|
Fade Gida Yatirim Sanayi Ticaret As
IS:FADE
|
Turkey | TL443.68 Million |
|
TAEYANG Corporation
KQ:053620
|
Korea | ₩35.38 Billion |
|
Venus Metals Corporation Ltd
AU:VMC
|
Australia | AU$353.13K |
|
Taylor Wimpey PLC
LSE:TW
|
UK | GBX2.07 Billion |
|
Lien Chang Electronic Enterprise Co Ltd
TW:2431
|
Taiwan | NT$171.19 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down P&K Skin Research Center Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 347740 asset base.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how P&K Skin Research Center Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for P&K Skin Research Center Co. Ltd (2018–2024)
The table below shows the annual total liabilities of P&K Skin Research Center Co. Ltd from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩5.10 Billion ≈ $3.46 Million |
+61.14% |
| 2023-12-31 | ₩3.17 Billion ≈ $2.15 Million |
-15.13% |
| 2022-12-31 | ₩3.73 Billion ≈ $2.53 Million |
-7.31% |
| 2021-12-31 | ₩4.03 Billion ≈ $2.73 Million |
-5.59% |
| 2020-12-31 | ₩4.27 Billion ≈ $2.89 Million |
+22.85% |
| 2019-12-31 | ₩3.47 Billion ≈ $2.35 Million |
+106.29% |
| 2018-12-31 | ₩1.68 Billion ≈ $1.14 Million |
-- |
About P&K Skin Research Center Co. Ltd
P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vi… Read more